Alon Abraham, Beatrice Abramovich, Tamar Banon, Clara Weil, Gabriel Chodick, Nurit Birman, Yaara Fainmesser, Vivian E Drory
BACKGROUND: There is an unmet need for real-world data regarding laboratory results, co-morbidities, and medication use prior to the first symptoms of amyotrophic lateral sclerosis (ALS). Researchers must identify specific subpopulations at risk for developing ALS and understand pathogenic mechanisms preceding the clinical presentation of ALS as well as possible subclinical disease manifestations. OBJECTIVES: To valuate the role of laboratory results, co-morbidities, and medication use prior to the first symptoms of patients with ALS in Israel so that specific subpopulations at risk for developing ALS can be identified and for possible subclinical disease manifestations...
September 2023: Israel Medical Association Journal: IMAJ